Robert Sessions's questions to Vivos Therapeutics Inc (VVOS) leadership • Q2 2025
Question
Robert Sessions from Water Tower Research asked about the recruitment process for Sleep Optimization (SO) teams, the company's M&A strategy post-SCN, management's prior experience with similar models, plans for refinancing its recent debt, and the potential timeline to reach cash flow breakeven.
Answer
CEO Kirk Huntsman detailed the SO team recruitment process, noting a robust labor pool and highlighting the management team's deep experience with similar models from the dental service organization (DSO) industry. He affirmed they will pursue new M&A opportunities concurrently with the SCN integration. Regarding financing, Huntsman stated they are actively seeking to reduce the cost of capital as the new, more predictable business model matures. He expressed a strong push and hope to achieve cash flow positivity sometime in Q4 2025.